Targovax to present at forthcoming conferences
Targovax, a clinical stage immuno-oncology company, developing targeted immunotherapy treatments for cancer patients, announces that members of its senior management team will participate in the following life sciences and investor conferences:Redeye Investor ForumStockholm, 1 June 2016Participants: Magnus Jäderberg (CMO)Presentation time: 18:00Venue: Redeye HQ, Mäster Samuelsgatan 42, Stockholm Redeye Investor ForumVästerås, 7 June 2016Participants: Magnus Jäderberg (CMO)Presentation time: 19:30Venue: Elite Stadshotellet, Stora Torget, Västerås Småbolagsdagen 2016